Eledon Pharmaceuticals
ELDN
ELDN
33 hedge funds and large institutions have $46M invested in Eledon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
6
Closed
1
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$4K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.9M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$2.1M |
| 3 |
CM
3
CM Management
Gulf Breeze,
Florida
|
$685K |
| 4 |
4
Morgan Stanley
New York
|
$208K |
| 5 |
5
BlackRock
New York
|
$538K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Pathstone Holdings
Englewood,
New Jersey
| $32.4K | – | – | – |
|
|
CCP
27
Clarity Capital Partners
Newport Beach,
California
| $28.6K | +$28.6K | +11,500 | New |
|
|
TSS
28
Two Sigma Securities
New York
| $27.5K | +$27.5K | +11,027 | New |
|
29
Bank of America
Charlotte,
North Carolina
| $17K | -$5 | -2 | -0% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3.82K | -$38.4K | -15,426 | -91% |
|
31
JPMorgan Chase & Co
New York
| $242 | +$15 | +6 | +7% |
|
32
Fidelity Investments
Boston,
Massachusetts
| $42 | – | – | – |
|
33
UBS Group
Zurich,
Switzerland
| $10 | -$137K | -54,997 | -100% |
|